and led by researchers from John Hopkins Medicine uncovered that two doses of psilocybin and supportive psychotherapy resulted in immediate, important antidepressant effects.This Viewpoint examines how US states are reforming laws to allow use of psychedelics for therapeutic use, but federal rules look at these agents being Agenda I drugs, along wi